CEL-SCI Corporation news

   Watch this stock
Showing stories 1 - 10 of about 11   

Articles published

CVM 1.96 +0.06 (3.16%)
price chart
CEL-SCI Announces Update on Arbitration against Former Clinical Research ...
Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving ...
Let's Take Some Time To Look Back: Calpine Corporation (CPN), CEL-SCI ...
The company during the last trade was able to reach a volume of 0.85 million shares. That activity is comparable to their recent volume average trend of nearly 0.18 million shares which they recorded over a period of three months.
What do Insider Trends Have to Say About Celsion Corporation (CLSN)?
Recent insider trends for Celsion Corporation (NASDAQ:CLSN) have caught the attention of investors. Analysts monitor insider data to understand the sentiment of a company's largest and most important shareholders.
Perkins Capital Management Inc Now Owns 912995 Shares In Cytori Therapeutics ...
Cytori Therapeutics, Inc. (NASDAQ:CYTX) is at least 30.74% than its current record low price of $0.28. There was a -7.82% decline on 11/10/2017 that led the price to move at $0.37.
Sprint Corporation (S) currently has a monthly volatility of 3.99%
Ultimately, through all this investigation into the company's performance the analyst decides whether their stock is a “buy,” sell” or hold.
Phillips 66 (PSX) fell -0.35 percent in the last trading session
Phillips 66 (PSX) shares fell and closed the day at $93.29, with the percent change of -0.35%. The company has its outstanding shares of 512.92 Million.
The Walt Disney Company (DIS) has its outstanding shares of 1.55 Billion
The Walt Disney Company (DIS) shares fell and closed the day at $97.81, with the percent change of -0.23%. The company has its outstanding shares of 1.55 Billion.
Gaithersburg immunotherapy biotech raises $2 million
The company's leadership also includes Chief Operating Officer Katherine Sacksteder, also formerly of Sequella, where she raised $15 million to support the development of that company's antibiotic pipeline.
Novartis Drug Delivers Superior Reductions In Retinal Thickness During Trial
Novartis brolucizumab (RTH258) demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity in nAMD, a leading cause of blindness.
PDCPD Market 2017 – MFG, WAYAND, Suemokko, POLIRIM, Artekno Oy, OTIS TARDA ...
Global PDCPD Market 2017 Analysis Report audits a Market Regions, Product Categories, with Sales, Business Revenue, Goods cost, PDCPD piece of the overall industry and Growth patterns, concentrating on driving PDCPD industry players, showcase size ...